Ursprung des Netzwerks ersten Grades von Shingo Tsuda
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
INDEE Medical, Inc.
 INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan.
4
| Subsidiary | Medical Specialties | 4 |
MENOU Corp.
 MENOU Corp. Packaged SoftwareTechnology Services MENOU Corp. provides services to make AI more accessible and easy to implement in the manufacturing industry. The company is based in Tokyo, Japan. The Japanese company's solutions include MENOU-TE, which automates visual inspections, and MENOU-IN, which allows for affordable AI visual inspections. The company was founded in 2019. The CEO is Reiteru Nishimoto.
3
| Holding Company | Packaged Software | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shingo Tsuda
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AJINOMOTO CO., INC. | Food: Specialty/Candy | Corporate Officer/Principal | |
Fujirebio, Inc.
 Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Medical Specialties | President | |
Quintiles Transnational Japan K.K.
 Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Waseda University | College/University | Undergraduate Degree | |
| Ortho-Clinical Diagnostics KK | Director/Board Member | ||
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Miscellaneous Commercial Services | President | |
| CHORDIA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Japan | 8 |
| Vereinigte Staaten | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Non-Durables | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 8 |
| President | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Shingo Tsuda
- Unternehmensverbindungen
